A Double-blind, Placebo-controlled, Randomised, Parallel-group, Phase II, Multi-centre Study to Assess the Efficacy, Safety and Tolerability of 4 Twice Daily Doses and 2 Once Daily Doses of AZD1981 Given as Tablets During 12 Weeks in Asthmatic Patients
A Double-blind, Placebo-controlled, Randomised, Parallel-group, Phase II, Multi-centre Study to Assess the Efficacy, Safety and Tolerability of 4 Twice Daily Doses and 2 Once Daily Doses of AZD1981 Given as Tablets During 12 Weeks in Asthmatic Patients
The study will assess the efficacy, safety and tolerability of AZD1981 compared to non-active compound in asthmatic patients.
Inclusion Criteria:
Exclusion Criteria:
Florian Polis, Santa Catarina, Brazil
Naka-gun, Ibaraki, Japan
Fujisawa-shi, Kanagawa, Japan
Kurashiki-shi, Okayama-ken, Japan
Chuo-ku, Tokyo, Japan
Itabashi-ku, Tokyo, Japan
Nakano-ku, Tokyo, Japan
Ohota-ku, Tokyo, Japan
Tg. Mures, Romania
Lyttleton, Centurion, South Africa
Vinytsa, Ukraine